This inventor holds 1 USPTO granted patent. Top assignee: Gene III Biotechnology Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Hongying Ju and an Eye-Care Composition Featuring L-Ergothioneine.
Introduction
Hongying Ju is an inventor associated with Nanjing, China, and Gene III Biotechnology Co., Ltd. The supplied information identifies 1 patent associated with Ju. Although the note refers to Ju as “she,” the supplied patent description does not establish further biographical details.
Latest Patents
Ju’s listed patent is titled “Eye Care Composition Containing L-Ergothioneine, and Preparation Method Therefor and Use Thereof.” It describes an eye-care composition containing L-ergothioneine, taurine, sodium hyaluronate, plant essential oil, p-benzenediboronic acid, an osmotic-pressure regulator, and water for injection.
The described preparation process combines sodium hyaluronate with water for injection, then adds taurine, L-ergothioneine, and p-benzenediboronic acid while adjusting the pH to 5–7.5. Plant essential oil is then added, and the osmotic pressure is adjusted to 250–350 mOsm/(kg·H₂O) before filtration, sterilization, and packaging. The patent description presents the composition as having stability and potential anti-inflammatory, moisturizing, and soothing effects for eye fatigue, itching, and dryness.
Career Highlights
The available information connects Ju’s patent work with Gene III Biotechnology Co., Ltd. The listed invention focuses on a formulated eye-care product and its preparation method.
Collaborations
Wei Ding and Juan Cao are identified as Ju’s coworkers. The supplied information does not specify their roles in the patent or the nature of their collaboration.
Conclusion
Hongying Ju’s listed patent concerns an L-ergothioneine eye-care composition and a method for preparing it, reflecting work in biotechnology and eye-care formulation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile